Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
clinical trials
gene therapy
life sciences
national blog main
national top stories
new york blog main
2
×
adeno-associated virus
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bluebird bio
cancer
chemotherapy
cisplatin
decibel therapeutics
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
hearing loss
joe burns
joshua brumm
kaleido biosciences
laurence reid
muscular dystrophy
myotonic dystrophy type 1
rare disease drugs
regenerative medicine
regeneron pharmaceuticals
rockefeller university
romesh subramanian
san diego blog main
san francisco blog main
startups
steven holtzman
susanna high
What
ago
2
×
medicines
therapeutics
2
×
adding
aiming
balance
biotechs
build
considering
data
decibel
diseases
drug
drugs
dyne
early
emerged
expected
experimental
eyes
focus
forms
genetic
having
hearing
humans
ipo
ipos
long
loss
med
muscle
pipeline
rare
reach
regenerative
strikes
various
worked
years
Language
unset
Current search:
therapeutics
×
ago
×
" new york blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus